141 related articles for article (PubMed ID: 38123344)
21. LINC00324 suppresses apoptosis and autophagy in nasopharyngeal carcinoma through upregulation of PAD4 and activation of the PI3K/AKT signaling pathway.
Chen H; Wei L; Luo M; Wang X; Zhu C; Huang H; Liu X; Lu H; Zhong Y
Cell Biol Toxicol; 2022 Dec; 38(6):995-1011. PubMed ID: 34322788
[TBL] [Abstract][Full Text] [Related]
22. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
Li W; Ma H; Liu M
Mol Biotechnol; 2021 Nov; 63(11):1081-1091. PubMed ID: 34236626
[TBL] [Abstract][Full Text] [Related]
23. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
24. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
Xie Z; Li W; Ai J; Xie J; Zhang X
J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
[TBL] [Abstract][Full Text] [Related]
25. ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
Zhuang YJ; Liao ZW; Yu HW; Song XL; Liu Y; Shi XY; Lin XD; Zhou TC
Cancer Biol Ther; 2015; 16(1):88-96. PubMed ID: 25482932
[TBL] [Abstract][Full Text] [Related]
26. microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1.
Gao R; Feng Q; Tan G
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189740
[No Abstract] [Full Text] [Related]
27. Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.
Hwang CF; Shiu LY; Su LJ; Yu-Fang Yin ; Wang WS; Huang SC; Chiu TJ; Huang CC; Zhen YY; Tsai HT; Fang FM; Huang TL; Chen CH
PLoS One; 2013; 8(12):e84218. PubMed ID: 24386352
[TBL] [Abstract][Full Text] [Related]
28. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
29. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
30. LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis.
Xie T; Du K; Liu W; Liu C; Wang B; Tian Y; Li R; Huang X; Lin J; Jian H; Zhang J; Yuan Y
Br J Cancer; 2022 Oct; 127(7):1239-1253. PubMed ID: 35864158
[TBL] [Abstract][Full Text] [Related]
31. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
Zhang W; Zhang Q; Cui Q; Xu Y
Hum Exp Toxicol; 2023; 42():9603271221150248. PubMed ID: 36607163
[TBL] [Abstract][Full Text] [Related]
32. ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma.
Hu Q; Lin X; Ding L; Zeng Y; Pang D; Ouyang N; Xiang Y; Yao H
Cancer Med; 2018 Aug; 7(8):3862-3874. PubMed ID: 29936709
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
Hu W; Wang Y; Zhang Q; Luo Q; Huang N; Chen R; Tang X; Li X; Luo H
Cell Signal; 2023 Oct; 110():110833. PubMed ID: 37543098
[TBL] [Abstract][Full Text] [Related]
34. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.
Zhou W; Feng X; Ren C; Jiang X; Liu W; Huang W; Liu Z; Li Z; Zeng L; Wang L; Zhu B; Shi J; Liu J; Zhang C; Liu Y; Yao K
Mol Cancer; 2013 Jun; 12():53. PubMed ID: 23758864
[TBL] [Abstract][Full Text] [Related]
36. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of miR-155 promotes apoptosis of nasopharyngeal carcinoma CNE-1 cells by targeting PI3K/AKT-FOXO3a signaling.
Wu S; Xie DL; Dai XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7391-7398. PubMed ID: 31539126
[TBL] [Abstract][Full Text] [Related]
38. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
Song L; Chen L; Luan Q; Kong Q
J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
[TBL] [Abstract][Full Text] [Related]
39. STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma.
Zhao Y; Yang L; He J; Yang H
Tumour Biol; 2017 Jul; 39(7):1010428317711644. PubMed ID: 28720063
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
